Glucocorticoid therapy and ocular hypertension

European Journal of Pharmacology

Volumn 787, Issue , 2016, Pages 57-71

  Dibas, Adnan ^a   Yorio, Thomas ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Glaucoma; Glucocorticoids; Steroid receptors; Trabecular meshwork

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; HYDROCORTISONE; KARYOPHERIN; MYOCILIN; NUCLEAR PROTEIN;

AGING; ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; GENE EXPRESSION REGULATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; INTRACRANIAL HYPERTENSION; INTRAOCULAR HYPERTENSION; NEGATIVE FEEDBACK; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; INTRAOCULAR PRESSURE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; OCULAR HYPERTENSION; RECEPTORS, GLUCOCORTICOID;

EID: 84978898122     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2016.06.018     Document Type: Article

References (236)

1. Adams, M., Meijer, O.C., Wang, J., Bhargava, A., Pearce, D., Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants. Mol. Endocrinol. 17 (2003), 2583–2592.
2. Adam, M.F., Belmouden, A., Binisti, P., Brézin, A.P., Valtot, F., Béchetoille, A., Dascotte, J.C., Copin, B., Gomez, L., Chaventré, A., Bach, J.F., Garchon, H.J., Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. Hum. Mol. Genet. 6 (1997), 2091–2097.
3. Akingbehin, A.O., Comparative study of the intraocular pressure effects of fluorometholone 0.1% versus dexamethasone 0.1%. Br. J. Ophthalmol. 67 (1983), 661–663.
4. Al Bakir, M., Butt, A.N., Swaminathan, R., Circulating 11beta-hydroxysteroid dehydrogenase type 1 mRNA and cardiovascular risk factors. Ann. N. Y. Acad. Sci. 1137 (2008), 283–289.
5. Anderson, S., Carreiro, S., Quenzer, T., Gale, D., Xiang, C., Gukasyan, H., Lafontaine, J., Cheng, H., Krauss, A., Prasanna, G., In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye. J. Ocul. Pharmacol. Ther. 25:3 (2009), 215–222.
6. Armaly, M.F., Effect of corticosteroids on intraocular pressure and fluid dynamics: II. The effect of dexamethasone on the glaucomatous eye. Arch. Ophthalmol. 70 (1963), 492–499.
7. Avenant, C., Ronacher, K., Stubsrud, E., Louw, A., Hapgood, J.P., Role of ligand dependent GR phosphorylation and half-life in determination of ligand-specific transcriptional activity. Mol. Cell. Endocrinol. 327 (2010), 72–88.
8. Bakri, S.J., Pulido, J.S., McCannel, C.A., Hodge, D.O., Diehl, N., Hillemeier, J., Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye 23:1 (2009), 181–185.
9. Bartlett, J.D., Woolley, T.W., Adams, C.M., Identification of high intraocular pressure responders to topical ophthalmic corticosteroids. J. Ocul. Pharmacol. 9:1 (1993), 35–45.
10. Beck, I.M., Vanden Berghe, W., Vermeulen, L., Yamamoto, K.R., Haegeman, G., De Bosscher, K., Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr. Rev. 30 (2009), 830–882.
11. Beck, I.M., Vanden Berghe, W., Vermeulen, L., Bougarne, N., Vander Cruyssen, B., Haegeman, G., De Bosscher, K., Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition. EMBO J. 27 (2008), 1682–1693.
12. Beger, C., Gerdes, K., Lauten, M., Expression and structural analysis of glucocorticoid receptor isoform gamma in human leukemia cells using an isoform-specific real-time polymerase chain reaction approach. Br. J. Haematol. 122 (2003), 245–252.
13. Bernstein, H.N., Mills, D.W., Becker, B., Steroid-induced elevation of intraocular pressure. Arch. Ophthalmol. 9 (1977), 1075–1080.
14. Bledsoe, R.K., Montana, V.G., Stanley, T.B., Delves, C.J., Apolito, C.J., McKee, D.D., Consler, T.G., Parks, D.J., Stewart, E.L., Willson, T.M., Lambert, M.H., Moore, J.T., Pearce, K.H., Xu, H.E., Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110 (2002), 93–105.
15. Blind, R.D., Garabedian, M.J., Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. J. Steroid Biochem. Mol. Biol. 109 (2008), 150–157.
16. Brady, C.J., Villanti, A.C., Law, H.A., Rahimy, E., Reddy, R., Sieving, P.C., Garg, S.J., Tang, J., Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database Syst. Rev., 12, 2016, 2.
17. Budzynski, E.S.A., López, F.J., Ward, K.W., 2009. BOL-303242-X, a selective glucocorticoid receptor agonist (SEGRA), offers a better in vivo side effect profile than dexamethasone on intraocular pressure elevation in normotensive rabbits. ARVO Annual Meeting. Fort Lauderdale (FL).
18. Burdge, G.C., Lillycrop, K.A., Phillips, E.S., Slater-Jefferies, J.L., Jackson, A.A., Hanson, M.A., Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J. Nutr. 139:6 (2009), 1054–1060.
19. Calvo, P., Ferreras, A., Al Adel, F., Wang, Y., Brent, M.H., Dexamethasone intravitreal implant as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumab. Br. J. Ophthalmol. 99:6 (2015), 723–726.
20. Cameron, A., Henley, D., Carrell, R., Zhou, A., Clarke, A., Lightman, S., Temperature-responsive release of cortisol from its binding globulin: a protein thermocouple. J. Clin. Endocrinol. Metab. 95 (2010), 4689–4695.
21. Cannarile, L., Zollo, O., D'Adamio, F., Ayroldi, E., Marchetti, C., Tabilio, A., Bruscoli, S., Riccardi, C., Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid hormone-induced gene. Cell Death Differ. 8 (2001), 201–203.
22. Cao, Y., Bender, I.K., Konstantinidis, A.K., Shin, S.C., Jewell, C.M., Cidlowski, J.A., Schleimer, R.P., Lu, N.Z., Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans. Blood 121:9 (2013), 1553–1562.
23. Carballo-Jane, E., Pandit, S., Santoro, J.C., Freund, C., Luell, S., Harris, G., Forrest, M.J., Sitlani, A., Skeletal muscle: a dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation. J. Steroid Biochem. Mol. Biol. 88 (2004), 191–201.
24. Carrigan, A., Walther, R.F., Salem, H.A., Wu, D., Atlas, E., Lefebvre, Y.A., Haché, R.J., An active nuclear retention signal in the glucocorticoid receptor functions as a strong inducer of transcriptional activation. J. Biol. Chem. 282 (2007), 10963–10971.
25. Chalepakis, G., Schaue, r M., Cao, X.A., Beato, M., Efficient binding of glucocorticoid receptor to its responsive element requires a dimer and DNA flanking sequences. DNA Cell Biol. 9:5 (1990), 355–368.
26. Charmandari, E., Gchrousos, G.P., Lambrou, G.I., Pavlaki, A., Koide, H., Man, Ng, Kino, T., Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One, 6, 2011, e25612.
27. Chen, W., Dang, T., Blind, R.D., Wang, Z., Cavasotto, C.N., Hittelman, A.B., Rogatsky, I., Logan, S.K., Garabedian, M.J., Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol. Endocrinol. 22 (2008), 1754–1766.
28. Christodoulopoulos, P., Leung, D.Y., Elliott, M.W., Hogg, J.C., Muro, S., Toda, M., Laberge, S., Hamid, Q.A., Increased number of glucocorticoid receptor-β-expressing cells in the airways in fatal asthma. J. Allergy Clin. Immunol. 106 (2000), 479–484.
29. Chrousos, G.P., Adrenocorticosteroids and adrenocortical antagonists. Katzung, B.G., Masters, S.B., Trevor, A.J., (eds.) Basic and Clinical Pharmacology, 2012, McGraw Hill Publishing, New York, 697–714.
30. Chrousos, G.P., Kino, T., Intracellular glucocorticoid signaling: a formly simple system turns stochastic. Sci. Stke., 2005, 48.
31. Clark, A.F., Mechanism of action of the angiostatic cortisone anecortave acetate. Surv. Ophthalmol. 52:Suppl. 1 (2007), S26–S34.
32. Clark, A.F., Wilson, K., McCartney, M.D., Miggans, S.T., Kunkle, M., Howe, W., Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 35 (1994), 281–294.
33. Clark, A.F., Wilson, K., De Kater, A.W., Allingham, R.R., McCartney, M.D., Dexamethasone-induced ocular hypertension in perfusion-cultured human eyes. Investig. Ophthalmol. Vis. Sci. 36 (1995), 478–489.
34. Connors, B.W., Tales of a dirty drug: carbenoxolone, gap junctions, and seizures. Epilepsy Curr. 12:2 (2012), 66–68.
35. Cope, C.L., Black, E., The production rate of cortisol in man. Lancet 14 (1958), 1020–1024.
36. Davies, L., Karthikeyan, N., Lynch, J.T., Sial, E.A., Gkourtsa, A., Demonacos, C., Krstic-Demonacos, M., Mol. Endocrinol. 22 (2008), 1331–1344.
37. Davies, T.G., Tonographic survey of the close relatives of patients with chronic simple glaucoma. Br. J. Ophthalmol. 52:1 (1968), 32–39.
38. De Bosscher, K., Vanden Berghe, W., Haegeman, G., Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene 25 (2006), 6868–6886.
39. De Bosscher, K., Vanden Berghe, W., Beck, I.M., Van Molle, W., Hennuyer, N., Hapgood, J., Libert, C., Staels, B., Louw, A., Haegeman, G., A fully dissociated compound of plant origin for inflammatory gene repression. Proc. Natl. Acad. Sci. U.S.A 102 (2005), 15827–15832.
40. de Lange, P., Segeren, C.M., Koper, J.W., Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res. 61 (2001), 3937–3941.
41. de Rooij, S.R., Costello, P.M., Veenendaal, M.V., Lillycrop, K.A., Gluckman, P.D., Hanson, M.A., Painter, R.C., Roseboom, T.J., Associations between DNA methylation of a glucocorticoid receptor promoter and acute stress responses in a large healthy adult population are largely explained by lifestyle and educational differences. Psychoneuroendocrinology 37:6 (2012), 782–788.
42. Derijk, R.H., Schaaf, M.J., Turner, G., Datson, N.A., Vreugdenhil, E., Cidlowski, J., de Kloet, E.R., Emery, P., Sternberg, E.M., Detera-Wadleigh, S.D., A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor beta-isoform mRNA is associated with rheumatoid arthritis. J. Rheumatol. 28 (2001), 2383–2388.
43. Deroo, B.J., Rentsch, C., Sampath, S., Young, J., DeFranco, D.B., Archer, T.K., Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol. Cell. Biol. 22 (2002), 4113–4123.
44. Dewint, P., Gossye, V., De Bosscher, K., Vanden Berghe, W., Van Beneden, K., Deforce, D., Van Calenbergh, S., Müller-Ladner, U., Vander Cruyssen, B., Verbruggen, G., A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J. Immunol. 180 (2008), 2608–2615.
45. Dibas, A., Yorio, T., Review of patent application on anti-glaucoma drugs. Expert Opin. Ther. Pat. 14 (2004), 1743–1762.
46. Dibas, A., Jiang, M., Fudala, R., Gryczynski, I., Gryczynski, Z., Clark, A.F., Yorio, T., Fluorescent protein-labeled glucocorticoid receptor alpha isoform trafficking in cultured human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 53:6 (2012), 2938–2950.
47. DuBois, D.C., Sukumaran, S., Jusko, W.J., Almon, R.R., Evidence for a glucocorticoid receptor beta splice variant in the rat and its physiological regulation in liver. Steroids 78 (2013), 312–320.
48. Drebert, Z., Bracke, M., Beck, I.M., Glucocorticoids and the non-steroidal., selective glucocorticoid receptor modulator, compound A, differentially affect colon cancer-derived myofibroblasts. J. Steroid Biochem. Mol. Biol. 149 (2015), 92–105.
49. Echeverría, P.C., Mazaira, G., Erlejman, A., Gomez-Sanchez, C., Piwien Pilipuk, G., Galigniana, M.D., Nuclear import of the glucocorticoid receptor-hsp90 complex through the nuclear pore complex is mediated by its interaction with Nup62 and importin beta. Mol. Cell. Biol. 29:17 (2009), 4788–4797.
50. Ettinger, B., Pressman, A., Shah, H.A., Who bears responsibility for glucocorticoid-exposed patients in a large health maintenance organization. J. Manag. Care Pharm. 7 (2001), 228–232.
51. Fan, B.J., Wang, D.Y., Tham, C.C., Lam, D.S., Pang, C.P., Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone. Investig. Ophthalmol. Vis. Sci. 49:5 (2008), 1886–1897.
52. Faralli, J.A., Gagen, D., Filla, M.S., Crotti, T.N., Peters, D.M., Dexamethasone increases αvβ3 integrin expression and affinity through a calcineurin/NFAT pathway. Biochim. Biophys. Acta 1833:12 (2013), 3306–3313.
53. Feibel, J., Kelly, M., Lee, L., Woolf, P., Loss of adrenocortical suppression after acute brain injury: role of increased intracranial pressure and brain stem function. J. Clin. Endocrinol. Metab. 57:6 (1983), 1245–1250.
54. Fingert, J.H., Clark, A.F., Craig, J.E., Alward, W.L., Snibson, G.R., McLaughlin, M., Tuttle, L., Mackey, D.A., Sheffield, V.C., Stone, E.M., Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Investig. Ophthalmol. Vis. Sci. 42 (2001), 145–152.
55. Fingert, J.H., Ying, L., Swiderski, R.E., Nystuen, A.M., Arbour, N.C., Alward, W.L., Sheffield, V.C., Stone, E.M., Characterization and comparison of the human and mouse GLC1A glaucoma genes. Genome Res. 8 (1998), 377–384.
56. Foster, C.S., Vitale, A.T., (eds.) Diagnosis and Treatment of Uveitis, 1st Ed., 2002, WB Saunders, St. Louis MO, 17–23.
57. Freedman, J., David, R., van der Walt, L.A., Luntz, M.H., Plasma cortisol suppression response in the South African black population with glaucoma. Br. J. Ophthalmol. 60:11 (1976), 786–788.
58. Freedman, N.D., Yamamoto, K.R., Importin 7 and importin alpha/importin beta are nuclear import receptors for the glucocorticoid receptor. Mol. Biol. Cell. 15:5 (2004), 2276–2286.
59. Frijters, R., Fleuren, W., Toonen, E.J., Tuckermann, J.P., Reichardt, H.M., van der Maaden, H., van Elsas, A., van Lierop, M.J., Dokter, W., de Vlieg, J., Alkema, W., Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC Genomics, 11, 2010, 359.
60. Friso, S., Pizzolo, F., Choi, S.W., Guarini, P., Castagna, A., Ravagnani, V., Carletto, A., Pattini, P., Corrocher, R., Olivieri, O., Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 199:2 (2008), 32332–32337.
61. Galliher-Beckley, A.J., Williams, J.G., Cidlowski, J.A., Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol. Cell. Biol. 31 (2011), 4663–4675.
62. Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J.J., Chrousos, G.P., Bornstein, S.R., Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16:1 (2002), 61–71.
63. Gathercole, L.L., Lavery, G.G., Morgan, S.A., Cooper, M.S., Sinclair, A.J., Tomlinson, J.W., Stewart, P.M., 11b-hydroxysteroid dehydrogenase 1: translational and therapeutic targets. Endocr. Rev. 34 (2013), 525–555.
64. Gelatt, K.N., Mackay, E.O., The ocular hypertensive effects of topical 0.1% dexamethasone in beagles with inherited glaucoma. J. Ocul. Pharmacol. Ther. 14 (1998), 57–66.
65. Gerometta, R., Podos, S.M., Candia, O.A., Wu, B., Malgor, L.A., Mittag, T., Danias, J., Steroid-induced ocular hypertension in normal cattle. Arch. Ophthalmol. 122 (2004), 1492–1497.
66. Gerometta, R., Podos, S.M., Danias, J., Candia, O.A., Steroid-induced ocular hypertension in normal sheep. Investig. Ophthalmol. Vis. Sci. 50 (2009), 669–673.
67. Goecke, A., Guerrero, J., Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications. Immunobiology 211:1–2 (2006), 85–96.
68. Gould, N.R., Siegel, H.S., Partial purification and characterization of chicken corticosteroid-binding globulin. Poult. Sci. 57 (1978), 1733–1739.
69. Gramlich, O.W., Beck, S., von Thun Und Hohenstein-Blaul, N., Boehm, N., Ziegler, A., Vetter, J.M., Pfeiffer, N., Grus, F.H., Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PLos One, 8, 2013, e57557.
70. Gritz, D.C., Wong, I.G., Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111 (2004), 491–500.
71. Haeck, I.M., Rouwen, T.J., Timmer-de Mik, L., de Bruin-Weller, M.S., Bruijnzeel-Koomen, C.A., Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts. J. Am. Acad. Dermatol. 64:2 (2011), 275–281.
72. Hakim, A., Barnes, P.J., Adcock, I.M., Usmani, O.S., Importin-7 mediates glucocorticoid receptor nuclear import and is impaired by oxidative stress, leading to glucocorticoid insensitivity. FASEB J. 27:11 (2013), 4510–4519.
73. Hamid, Q.A., Wenzel, S.E., Hauk, P.J., Tsicopoulos, A., Wallaert, B., Lafitte, J.J., Chrousos, G.P., Szefler, S.J., Leung, D.Y., Increased glucocorticoid receptor β in airway cells of glucocorticoid-insensitive asthma. Am. J. Respir. Crit. Care Med. 159 (1999), 1600–1604.
74. Hammond, G.L., Molecular properties of corticosteroid binding globulin and the sex-steroid binding proteins. Endocr. Rev. 11 (1990), 65–79.
75. Hammond, G.L., Smith, C.L., Underhill, D.A., Molecular studies of corticosteroid binding globulin structure, biosynthesis and function. J. Steroid Biochem. Mol. Biol. 40 (1991), 755–762.
76. Hauk, P.J., Goleva, E., Strickland, I., Vottero, A., Chrousos, G.P., Kisich, K.O., Leung, D.Y., Increased glucocorticoid receptor β expression converts mouse hybridoma cells to a corticosteroid-insensitive phenotype. Am. J. Respir. Cell Mol. Biol. 27 (2002), 361–367.
77. Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H.J., Herrlich, P., Cato, A.C., A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13 (1994), 4087–4095.
78. Heinz, C., Koch, J.M., Zurek-Imhoff, B., Heiligenhaus, A., Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul. Immunol. Inflamm. 17:4 (2009), 243–248.
79. Henschkowski, J., Stuck, A.E., Frey, B.M., Gillmann, G., Dick, B., Frey, F.J., Mohaupt, M.G., Age-dependent decrease in 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) activity in hypertensive patients. Am. J. Hypertens 21:6 (2008), 644–649.
80. Herbert, H.M., Viswanathan, A., Jackson, H., Lightman, S.L., Risk factors for elevated intraocular pressure in uveitis. J. Glaucoma 13:2 (2004), 96–99.
81. Hinds, T.D. Jr., Ramakrishnan, S., Cash, H.A., Stechschulte, L.A., Heinrich, G., Najjar, S.M., Sanchez, E.R., Discovery of glucocorticoid receptor-beta in mice with a role in metabolism. Mol. Endocrinol. 24 (2010), 1715–1727.
82. Holmstrom, S., Van Antwerp, M.E., Iñiguez-Lluhi, J.A., Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy. Proc. Natl. Acad. Sci. USA 100 (2003), 15758–15763.
83. Holmstrom, S.R., Chupreta, S., So, A.Y., Iniguez-Lluhi, J.A., SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. Mol. Endocrinol. 22 (2008), 2061–2075.
84. Holownia, A., Mroz, R.M., Kolodziejczyk, A., Chyczewska, E., Braszko, J.J., Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy. Eur. J. Med. Res. 4:Suppl. (2009), S108–S111.
85. Honda, M., Orii, F., Ayabe, T., Imai, S., Ashida, T., Obara, T., Kohgo, Y., Expression of glucocorticoid receptor β in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology 11 (2000), 859–866.
86. Huang, P., Qi, Y., Xu, Y.S., Liu, J., Liao, D., Zhang, S.S., Zhang, C., Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma. J. Glaucoma 19:5 (2010), 324–330.
87. Iranmanesh, A., Lizarralde, G., Veldhuis, J.D., Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73 (1991), 1081–1088.
88. Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P.J., Adcock, I.M., Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 203 (2006), 7–13.
89. Jain, A., Wordinger, R.J., Yorio, T., Clark, A.F., Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 53:2 (2012), 857–866.
90. Jensen Peña, C., Monk, C., Champagne, F.A., Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. PLoS One, 7(6), 2012, e39791.
91. Jewell, C.M., Scoltock, A.B., Hamel, B.L., Yudt, M.R., Cidlowski, J.A., Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells. Mol. Endocrinol. 26 (2012), 244–256.
92. Johansson-Haque, K., Palanichamy, E., Okret, S., Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP. J. Mol. Endocrinol. 41:4 (2008), 239–249.
93. Johnson, D., Gottanka, J., Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch. Ophthalmol. 115:3 (1997), 375–383.
94. Johnson, D.H., Bradley, J.M., Acott, T.S., The effect of dexamethasone on glycosaminoglycans of human trabecular meshwork in perfusion organ culture. Investig. Ophthalmol. Vis. Sci. 31 (1990), 2568–2571.
95. Jones, R., Rhee, D.J., Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr. Opin. Ophthalmol. 17 (2006), 163–167.
96. Kassel, O., Herrlich, P., Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol. Cell. Endocrinol. 275 (2007), 13–29.
97. Kass, M.A., Krupin, T., Becker, B., Plasma cortisol suppression test used to predict the development of primary open-angle glaucoma. Am. J. Ophthalmol. 82:3 (1976), 496–497.
98. Kelly, A., Bowen, H., Jee, Y.K., Mahfiche, N., Soh, C., Lee, T., Hawrylowicz, C., Lavender, P., The glucocorticoid receptor beta isoform can mediate transcriptional, repression by recruiting histone deacetylases. J. Allergy Clin. Immunol. 121 (2008), 203–208.
99. Kiddee, W., Trope, G.E., Sheng, L., Beltran-Agullo, L., Smith, M., Strungaru, M.H., Baath, J., Buys, Y.M., Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv. Ophthalmol. 58:4 (2013), 291–310.
100. Kino, T., Manoli, I., Kelkar, S., Wang, Y., Su, Y.A., Chrousos, G.P., Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity. Biochem. Biophys. Res. Commun. 381 (2009), 671–675.
101. Klemetti, A., The dexamethasone provocative test: a predictive tool for glaucoma?. Acta Ophthalmol. 68:1 (1990), 29–33.
102. Kostadinova, R.M., Nawrocki, A.R., Frey, F.J., Frey, B.M., Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroiddehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1. FASEB J. 19:6 (2005), 650–652.
103. Kwok, A.K., Lam, D.S., Ng, J.S., Fan, D.S., Chew, S.J., Tso, M.O., Ocular hypertensive response to topical steroids in children. Ophthalmology 104 (1997), 2112–2116.
104. Krett, N.L., Pillay, S., Moalli, P.A., A variant glucocorticoid receptor messenger RNA is expressed in multiple myeloma patients. Cancer Res. 55 (1995), 2727–2729.
105. Kubota, R., Kudoh, J., Mashima, Y., Asakawa, S., Minoshima, S., Hejtmancik, J.F., Oguchi, Y., Shimizu, N., Genomic organization of the human myocilin gene (MYOC) responsible for primary open angle glaucoma (GLC1A). Biochem. Biophys. Res. Commun. 242 (1998), 396–400.
106. Kuo, T., Lew, M.J., Mayba, O., Harris, C.A., Speed, T.P., Wang, J.C., Genome-wide analysis of glucocorticoid receptor-binding sites in myotubes identifies gene networks modulating insulin signaling. Proc. Natl. Acad. Sci. USA 109:28 (2012), 11160–11165.
107. Lam, D.S., Fan, D.S., Ng, J.S., Yu, C.B., Wong, C.Y., Cheung, A.Y., Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial. Clin. Exp. Ophthalmol. 33 (2005), 252–258.
108. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G., Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin. Endocrinol. 41 (1994), 351–357.
109. Le Drean, Y., Mincheneau, N., Le Goff, P., Michel, D., Potentiation of glucocorticoid receptor transcriptional activity by sumoylation. Endocrinology 143 (2002), 3482–3489.
110. Leung, D.Y.M., Hamid, Q., Vottero, A., Szefler, S.J., Surs, W., Minshall, E., Chrousos, G.P., Klemm, D.J., Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J. Exp. Med. 186 (1997), 1567–1574.
111. Levin, D.S., Han, D.P., Dev, S., Wirostko, W.J., Mieler, W.F., Connor, T.B., George, V., Eastwood, D., Subtenon's depot corticosteroid injections in patients with a history of corticosteroid-induced intraocular pressure elevation. Am. J. Ophthalmol. 133:2 (2002), 196–202.
112. Lewis-Tuffin, L.J., Cidlowski, J.A., The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann. N. Y. Acad. Sci. 1069 (2006), 1–9.
113. Lewis-Tuffin, L.J., Jewell, C.M., Bienstock, R.J., Collins, J.B., Cidlowski, J.A., Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol. Cell. Biol. 27 (2007), 2266–2282.
114. Li, A., Leung, C.T., Peterson-Yantorno, K., Stamer, W.D., Civan, M.M., Cytoskeletal dependence of adenosine triphosphate release by human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 52:11 (2011), 7996–8005.
115. Lim, J.I., Niec, M., Wong, V., One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD. Br. J. Ophthalmol. 99:5 (2015), 618–623.
116. Lin, D.Y., Huang, Y.S., Jeng, J.C., Kuo, H.Y., Chang, C.C., Chao, T.T., Ho, C.C., Chen, Y.C., Lin, T., Fang, P., Hung, H.I., Suen, C.C., Hwang, C.S., Chang, M.J., Maul, K.S., Shih, H. M, G.G., Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24 (2006), 341–354.
117. Lin, H.Y., Muller, Y.A., Hammond, G.L., Molecular and structural basis of steroid hormone binding and release from corticosteroid-binding globulin. Mol. Cell. Endocrinol. 316 (2010), 3–12.
118. Lo, W.R., Rowlette, L.L., Caballero, M., Yang, P., Hernandez, M.R., Borrás, T., Tissue differential microarray analysis of dexamethasone induction reveals potential mechanisms of steroid glaucoma. Investig. Ophthalmol. Vis. Sci. 44:2 (2003), 473–485.
119. Longui, C.A., Vottero, A., Adamson, P.C., Cole, D.E., Kino, T., Monte, O., Chrousos, G.P., Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia. Horm. Metab. Res. 32 (2000), 401–406.
120. Lu, N.Z., Cidlowski, J.A., Translational regulatory mechanisms generate N-terminal, glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell. 18:3 (2005), 331–342.
121. Lorenzetti, O.J., Effects of corticosteroids on ocular dynamics in rabbits. J. Pharmacol. Exp. Ther. 175 (1970), 763–772.
122. McCarty, G.R., Schwartz, B., Increased plasma noncortisol glucocorticoid activity in open-angle glaucoma. Investig. Ophthalmol. Vis. Sci. 32 (1991), 1600–1608.
123. Melander, O., Orho-Melander, M., Bengtsson, K., Lindblad, U., Råstam, L., Groop, L., Hulthén, U.L., Association between a variant in the 11 β-hydroxysteroid dehydrogenase type 2 gene and primary hypertension. J. Hum. Hypertens. 14 (2000), 819–823.
124. Meredig, W.E., Pulhorn, G., Plasma cortisol level in patients suffering from glaucoma. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 213 (1980), 215–218.
125. Meulenberg, P.M., Hofman, J.A., Differences between concentrations of salivary cortisol and cortisone and of free cortisol and cortisone in plasma during pregnancy and postpartum. Clin. Chem. 36 (1990), 70–75.
126. Meyer, T., Gustafsson, J.A., Carlstedt-Duke, J., Glucocorticoid-dependent transcriptional repression of the osteocalcin gene by competitive binding at the TATA box. DNA Cell Biol. 16:8 (1997), 919–927.
127. Moalli, P.A., Pillay, S., Krett, N.L., Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells. Cancer Res. 53 (1993), 3877–3879.
128. Morin, B., Nichols, L.A., Holland, L.J., Flanking sequence composition differentially affects the binding and functional characteristics of glucocorticoid receptor homo- and heterodimers. Biochemistry 45:23 (2006), 7299–7306.
129. Nagy, Z., Acs, B., Butz, H., Feldman, K., Marta, A., Szabo, P.M., Baghy, K., Pazmany, T., Racz, K., Liko, I., Patocs, A., Overexpression of GRβ in colonic mucosal cell line partly reflects altered gene expression in colonic mucosa of patients with inflammatory bowel disease. J. Steroid Biochem. Mol. Biol. 155:Pt A (2016), 76–84.
130. Nehme, A., Lobenhofer, E.K., Stamer, W.D., Edelman, J.L., Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells. BMC Med. Genom., 2, 2009, 58.
131. Neri, P., Azuara-Blanco, A., Forrester, J.V., Incidence of glaucoma in patients with uveitis. J. Glaucoma 13 (2004), 461–465.
132. Newnham, J.P., Is prenatal glucocorticoid administration another origin of adult disease?. Clin. Exp. Pharmacol. Physiol. 28:11 (2001), 957–961.
133. Ng, J.S., Fan, D.S., Young, A.L., Yip, N.K., Tam, K., Kwok, A.K., Lam, D.S., Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon. Ophthalmology 107 (2000), 2097–2100.
134. Nixon, M., Andrew, R., Chapman, K.E., It takes two to tango: dimerization of glucocorticoid receptor and its anti-inflammatory functions. Steroids 78 (2013), 59–68.
135. Noble, S., Goa, K.L., Loteprednol etabonate: clinical potential in the management of ocular inflammation. BioDrugs 10:4 (1998), 329–339.
136. Nusbaum, D.M., Wu, S.M., Frankfort, B.J., Elevated intracranial pressure causes optic nerve and retinal, ganglion cell degeneration in mice. Exp. Eye Res. 136 (2015), 38–44.
137. Oakley, R.H., Sar, M., Cidlowski, J.A., The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271:16 (1996), 9550–9559.
138. Oakley, R.H., Cidlowski, J.A., Cellular processing of glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 268 (2011), 3177–3184.
139. Oakley, R.H., Cidlowski, J.A., The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J. Allergy Clin. Immunol. 132 (2013), 1033–1044.
140. Orii, F., Ashida, T., Nomura, M., Maemoto, A., Fujiki, T., Ayabe, T., Imai, S., Saitoh, Y., Kohgo, Y., Quantitative analysis for human glucocorticoid receptor α/β mRNA in IBD. Biochem. Biophys. Res. Commun. 296 (2002), 1286–1294.
141. Overman, R.A., Yeh, J.Y., Deal, C.L., Prevalence of oral glucocorticoid usage in the United States: a general, population perspective. Arthritis Care Res. 65:2 (2013), 294–298.
142. Paakinaho, V., Kaikkonen, S., Makkonen, H., Benes, V., Palvimo, J.J., Sumoylation regulates the chromatin occupancy and anti-proliferative gene programs of glucocorticoid receptor. Nucleic Acids Res. 42:3 (2014), 1575–1592.
143. Parente, L., Solito, E., Association between glucocorticosteroids and lipocortin 1. Trends Pharmacol. Sci., 15, 1994, 362.
144. Patel, R., Williams-Dautovich, J., Cummins, C.L., Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues. Mol. Endocrinol. 28:7 (2014), 999–1011.
145. Paterson, G., Studies of the response to topical dexamethasone of glaucoma relatives. Trans. Ophthalmol. Soc. 85 (1965), 295–305.
146. Payette, H., Roubenoff, R., Jacques, P.F., Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J. Am. Geriatr. Soc. 51 (2003), 1237–1243.
147. Presman, D.M., Ogara, M.F., Stortz, M., Alvarez, L.D., Pooley, J.R., Schiltz, R.L., Grøntved, L., Johnson, T.A., Mittelstadt, P.R., Ashwell, J.D., Ganesan, S., Burton, G., Levi, V., Hager, G.L., Pecci, A., Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor. PLoS Biol., 12, 2014, e1001813.
148. Picard, D., Yamamoto, K.R., Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J. 6 (1987), 3333–3340.
149. Qiu, X., Wu, K., Lin, X., Liu, Q., Ye, Y., Yu, M., Dexamethasone increases Cdc42 expression in human TM-1 cells. Curr. Eye Res. 40:3 (2015), 290–299.
150. Quigley, H.A., Brown, A.T., The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 90 (2006), 262–267.
151. Raghunathan, V.K., Morgan, J.T., Park, S.A., Weber, D., Phinney, B.S., Murphy, C.J., Russell, P., Dexamethasone Stiffens Trabecular Meshwork, Trabecular Meshwork Cells and Matrix. Investig. Ophthalmol. Vis. Sci. 56:8 (2015), 4447–4459.
152. Rauz, S., Walker, E.A., Shackleton, C.H., Hewison, M., Murray, P.I., Stewart, P.M., Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. Investig. Ophthalmol. Vis. Sci. 42 (2001), 2037–2042.
153. Ray, S., Mehra, K.S., Plasma cortisol in glaucoma. Ann. Ophthalmol. 9 (1977), 1151–1154.
154. Ray, D.W., Davis, J.R., White, A., Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res. 56 (1996), 3276–3280.
155. Reddy, T.E., Pauli, F., Sprouse, R.O., Neff, N.F., Newberry, K.M., Garabedian, M.J., Myers, R.M., Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 19:12 (2009), 2163–2171.
156. Rozsa, F.W., Reed, D.M., Scott, K.M., Pawar, H., Moroi, S.E., Kijek, T.G., Krafchak, C.M., Othman, M.I., Vollrath, D., Elner, V.M., Richards, J.E., Gene expression profile of human trabecular meshwork cells in response to long-term dexamethasone exposure. Mol. Vis. 12 (2006), 125–141.
157. Rozsíval, P., Hampl, R., Obenberger, J., Stárka, L., Rehák, S., Aqueous humor and plasma cortisol levels in glaucoma and cataract patients. Curr. Eye Res. 1:7 (1981), 391–396.
158. Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., Schütz, G., DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 (1998), 531–541.
159. Reynolds, P.D., Ruan, Y., Smith, D.F., Scammell, J.G., Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J. Clin. Endocrinol. Metab. 84 (1999), 663–669.
160. Rivers, C., Levy, A., Hancock, J., Lightman, S., Norman, M., Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J. Clin. Endocrinol. Metab. 84:11 (1999), 4283–4286.
161. Robertson, S., Allie-Reid, F., Vanden Berghe, W., Visser, K., Binder, A., Africander, D., Vismer, M., De Bosscher, K., Hapgood, J., Haegeman, G., Louw, A., Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound A. J. Biol. Chem. 285 (2010), 8061–8075.
162. Robertson, S., Hapgood, J.P., Louw, A., Glucocorticoid receptor concentration and the ability to dimerize influence nuclear translocation and distribution. Steroids 78 (2013), 182–194.
163. Robertson, S., Rohwer, J.M., Hapgood, J.P., Louw, A., Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture model. PLoS One, 8, 2013, e64831.
164. Robin, A.L., Clark, A.F., Covert, D.W., Krueger, S., Bergamini, M.V., Landry, T.A., Dickerson, J.E. Jr., Scheib, S.A., Realini, T., Defaller, J.M., Cagle, G.D., Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation. Am. J. Ophthalmol. 147:1 (2008), 45–50.
165. Rönkkö, S., Rekonen, P., Kaarniranta, K., Puustjärvi, T., Teräsvirta, M., Uusitalo, H., Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 245:5 (2007), 697–704.
166. Rosen, J., Miner, J.N., The search for safer glucocorticoid receptor ligands. Endocr. Rev. 26 (2005), 452–464.
167. Rosenberg, S., Levene, R., Suppression of plasma cortisol in normal. Arch. Ophthalmol. 92 (1974), 6–9.
168. Ruiz, M., Lind, U., Gåfvels, M., Eggertsen, G., Carlstedt-Duke, J., Nilsson, L., Holtmann, M., Stierna, P., Wikström, A.C., Werner, S., Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin. Endocrinol. 55 (2001), 363–371.
169. Russcher, H., Smit, P., van den Akker, E.L., van Rossum, E.F., Brinkmann, A.O., de Jong, F.H., Lamberts, S.W., Koper, J.W., Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J. Clin. Endocrinol. Metab. 90 (2005), 5804–5810.
170. Savory, J.G., Hsu, B., Laquian, I.R., Giffin, W., Reich, T., Haché, R.J., Lefebvre, Y.A., Discrimination between NL1- and NL2-mediated nuclear localization of the glucocorticoid receptor. Mol. Cell. Biol. 19 (1999), 1025–1037.
171. Sawada, H., Fukuchi, T., Tanaka, T., Abe, H., Tumor necrosis factor-alpha concentrations in the aqueous humor of patients with glaucoma. Investig. Ophthalmol. Vis. Sci. 51:2 (2010), 903–906.
172. Sawaguchi, K., Nakamura, Y., Nakamura, Y., Sakai, H., Sawaguchi, S., Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model. Ophthalmic Res. 37 (2005), 235–242.
173. Scammell, J.G., Denny, W.B., Valentine, D.L., Smith, D.F., Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen. Comp. Endocrinol. 124:2 (2001), 152–165.
174. Schacke, H., Docke, W.D., Asadullah, K., Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 96 (2002), 23–43.
175. Schaaf, M.J., Champagne, D., van Laanen, I.H., van Wijk, D.C., Meijer, A.H., Meijer, O.C., Spaink, H.P., Richardson, M.K., Discovery of a functional glucocorticoid receptor beta-isoform in zebrafish. Endocrinology 149 (2008), 1591–1599.
176. Selım, A., Koçak, N., Aslankara, H., Kaynak, S., Comparative study of photodynamic therapy monotherapy versus triple management in age-related macular degeneration. Turk. J. Med Sci. 44:5 (2014), 889–895.
177. Sharma, A., Aoun, P., Wigham, J., Weist, S., Veldhuis, J.D., Gender determines ACTH recovery from hypercortisolemia in healthy older humans. Metabolism 62:12 (2013), 1819–1829.
178. Schwartz, B., Levene, R.Z., Plasma cortisol differences between normal and glaucomatous patients. Arch. Ophthalmol. 87 (1972), 369–377.
179. Schwartz, J.T., Reuling, F.H. Jr., Feinleib, M., Garrison, R.J., Collie, D.J., Twin heritability study of the corticosteroid response. Trans. Am. Acad. Ophthalmol. Otolaryngol. 77:2 (1973), 126–136.
180. Schwartz, B., McCarty, G., Increased plasma free cortisol in ocular hypertension and open angle glaucoma. Arch. Ophthalmol. 105 (1987), 1060–1065.
181. Sen, H.N., Vitale, S., Gangaputra, S.S., Nussenblatt, R.B., Liesegang, T.L., Levy-Clarke, G.A., Rosenbaum, J.T., Suhler, E.B., Thorne, J.E., Foster, C.S., Jabs, D.A., Kempen, J.H., Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology 121:11 (2014), 2275–2286.
182. Shahidi, H., Vottero, A., Stratakis, C.A., Taymans, S.E., Karl, M., Longui, C.A., Chrousos, G.P., Daughaday, W.H., Gregory, S.A., Plate, J.M., Imbalanced expression of the glucocorticoid receptor isoforms in cultured lymphocytes from a patient with systemic glucocorticoid resistance and chronic lymphocytic leukemia. Biochem. Biophys. Res. Commun. 254 (1999), 559–565.
183. Shepard, A.R., Conrow, R.E., Pang, I.H., Jacobson, N., Rezwan, M., Rutschmann, K., Auerbach, D., Sriramaratnam, R., Cornish, V.W., Identification of PDE6D as a molecular target of anecortave acetate via a methotrexate-anchored yeast three-hybrid screen. Chem. Biol 8 (2013), 549–558.
184. Siiteri, P.K., Murai, J.T., Hammond, G.L., Nisker, J.A., Raymoure, W.J., Kuhn, R.W., The serum transport of steroid hormones. Recent Prog. Horm. Res. 38 (1982), 457–510.
185. Silva, C.M., Powell-Oliver, F.E., Jewell, C.M., Sar, M., Allgood, V.E., Cidlowski, J.A., Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 59 (1994), 436–442.
186. Sinclair, A.J., Walker, E.A., Burdon, M.A., van Beek, A.P., Kema, I.P., Hughes, B.A., Murray, P.I., Nightingale, P.G., Stewart, P.M., Rauz, S., Tomlinson, J.W., Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation?. J. Clin. Endocrinol. Metab. 95:12 (2010), 5348–5356.
187. Singh, I.P., Ahmad, S.I., Yeh, D., Challa, P., Herndon, L.W., Allingham, R.R., Lee, P.P., Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am. J. Ophthalmol. 138 (2004), 286–287.
188. Smith, C.L., Corticosteroid glaucoma: a summary and review of the literature. Am. J. Med. Sci. 252 (1966), 239–244.
189. Sousa, A.R., Lane, S.J., Cidlowski, J.A., Staynov, D.Z., Lee, T.H., Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor β-isoform. J. Allergy Clin. Immunol. 105 (2000), 943–950.
190. Stahn, C., Buttgereit, F., Genomic and nongenomic effects of glucocorticoids. Nat. Clin. Pract. Rheumatol. 4 (2008), 525–533.
191. Stamer, W.D., Hoffman, E.A., Kurali, E., Krauss, A.H., Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. Investig. Ophthalmol. Vis. Sci. 54:3 (2013), 2100–2107.
192. Stewart, R.H., Kimbrough, R.L., Intraocular pressure response to topically administered fluorometholone. Arch. Ophthalmol. 97 (1979), 2139–2140.
193. Stokes, J., Noble, J., Brett, L., Phillips, C., Seckl, J.R., O'Brien, C., Andrew, R., Distribution of glucocorticoid and mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenases in human and rat ocular tissues. Investig. Ophthalmol. Vis. Sci. 41 (2000), 1629–1638.
194. Stokes, J., Walker, B.R., Campbell, J.C., Seckl, J.R., O'Brien, C., Andrew, R., Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma. Investig. Ophthalmol. Vis. Sci. 44:12 (2003), 5163–5167.
195. Stone, E.M., Fingert, J.H., Alward, W.L., Nguyen, T.D., Polansky, J.R., Sunden, S.L., Nishimura, D., Clark, A.F., Nystuen, A., Nichols, B.E., Mackey, D.A., Ritch, R., Kalenak, J.W., Craven, E.R., Sheffield, V.C., Identification of a gene that causes primary open angle glaucoma. Science 275 (1997), 668–670.
196. Sundahl, N., Bridelance, J., Libert, C., De Bosscher, K., Beck, I.M., Selective glucocorticoid receptor modulation: new directions with non-steroidal, scaffolds. Pharmacol. Ther. 152 (2015), 28–41.
197. Surjit, M., Ganti, K.P., Mukherji, A., Ye, T., Hua, G., Metzger, D., Li, M., Chambon, P., Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145:2 (2011), 224–241.
198. Suzuki, T., Sasano, H., Kaneko, C., Ogawa, S., Darnel, A.D., Krozowski, Z.S., Immunohistochemical distribution of 11 beta-hydroxysteroid dehydrogenase in human eye. Mol. Cell. Endocrinol. 173 (2001), 121–125.
199. Takai, Y., Tanito, M., Ohira, A., Multiplex cytokine analysis of aqueous humor in eyes with primary open-angle glaucoma, exfoliation glaucoma, and cataract. Investig. Ophthalmol. Vis. Sci. 53:1 (2012), 241–247.
200. Tamm, E.R., Fuchshofer, R., What increases outflow resistance in primary open-angle glaucoma?. Surv. Ophthalmol. 52:Suppl. 2 (2007), S101–S104.
201. Tanaka, M., Nishi, M., Morimoto, M., Sugimoto, T., Kawata, M., Yellow fluorescent protein-tagged and cyan fluorescent protein-tagged imaging analysis of glucocorticoid receptor and importins in single living cells. Endocrinology 144:9 (2003), 4070–4079.
202. Tao, T., Lan, J., Lukacs, G.L., Haché, R.J., Kaplan, F., Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 35:6 (2006), 668–680.
203. Tawara, A., Tou, N., Kubota, T., Harada, Y., Yokota, K., Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid-induced glaucoma. Graefes Arch. Clin. Exp. Ophthalmol. 246 (2008), 1021–1028.
204. Tektas, O.Y., Lütjen-Drecoll, E., Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp. Eye Res. 88 (2009), 769–775.
205. Thomas-Chollier, M., Watson, L.C., Cooper, S.B., A naturally occurring insertion of a single amino acid rewires transcriptional regulation by glucocorticoid receptor isoforms. Proc. Natl. Acad. Sci. USA 110 (2013), 17826–17831.
206. Torpy, D.J., Ho, J.T., Corticosteroid-binding globulin gene polymorphisms: clinical implications and links to idiopathic chronic fatigue disorders. Clin. Endocrinol. 67 (2007), 161–167.
207. Tripathi, R.C., Kirschner, B.S., Kipp, M., Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure. Gastroenterology 102 (1992), 1957–1961.
208. Tyrka, A.R., Price, L.H., Marsit, C., Walters, O.C., Carpenter, L.L., Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS One, 7(1), 2012, e30148.
209. Uings, I.J., Needham, D., Matthews, J., Haase, M., Austin, R., Angell, D., Leavens, K., Holt, J., Biggadike, K., Farrow, S.N., Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile. Br. J. Pharmacol. 169:6 (2013), 1389–1403.
210. Vadot, E., Epidemiology of intermediate uveitis: a prospective study in Savoy. Dev. Ophthalmol. 23 (1992), 33–34.
211. Vakalis, N., Echiadis, G., Pervena, A., Deligiannis, I., Kavalarakis, E., Giannikakis, S., Papaefthymiou, Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative AMD. Sci. Rep., 5, 2015, 8627, 10.1038/srep08627.
212. Van Cauter, E., Leproult, R., Kupfer, D.J., Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81 (1996), 2468–2473.
213. van Staa, T.P., Leufkens, H.G., Abenhaim, L., Begaud, B., Zhang, B., Cooper, C., Use of oral corticosteroids in the United Kingdom. QJM 93 (2000), 105–111.
214. Webster, J.C., Oakley, R.H., Jewell, C.M., Cidlowski, J.A., Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. USA 98 (2001), 6865–6870.
215. Weinreb, R.N., Polansky, J.R., Kramer, S.G., Baxter, J.D., Acute effects of dexamethasone on intraocular pressure in glaucoma. Investig. Ophthalmol. Vis. Sci. 26 (1985), 170–175.
216. Weinstein, B.I., Munnangi, P., Gordon, G.G., Southren, A.L., Defects in cortisol-metabolizing enzymes in primary open-angle glaucoma. Investig. Ophthalmol. Vis. Sci. 26:6 (1985), 890–893.
217. Westberry, J.M., Sadosky, P.W., Hubler, T.R., Gross, K.L., Scammell, J.G., Glucocorticoid resistance in squirrel monkeys results from a combination of a transcriptionally incompetent glucocorticoid receptor and overexpression of the glucocorticoid receptor co-chaperone FKBP51. J. Steroid Biochem. Mol. Biol. 100:1–3 (2006), 34–41.
218. Westphal, U., Steroid-protein interactions II. Monogr. Endocrinol. 27 (1986), 1–603.
219. Whitlock, N.A., McKnight, B., Corcoran, K.N., Rodriguez, L.A., Rice, D.S, D.S., Increased intraocular pressure in mice treated with dexamethasone. Investig. Ophthalmol. Vis. Sci. 51 (2010), 6496–6503.
220. Wiggs, J.L., Allingham, R.R., Vollrath, D., Jones, K.H., De La Paz, M., Kern, J., Patterson, K., Babb, V.L., Del Bono, E.A., Broomer, B.W., Pericak-Vance, M.A., Haines, J.L., Prevalence of mutations in TIGR/Myocilin in patients with adult and juvenile primary open-angle glaucoma. Am. J. Hum. Genet. 63 (1998), 1549–1552.
221. Will, C.L., Luhrmann, R., Spliceosome structure and function. Cold Spring Harb. Perspect. Biol., 3, 2011, 7.
222. Wostyn, P., De Groot, V., Van Dam, D., Audenaert, K., Killer, H.E., De Deyn, P.P., Fast circulation of cerebrospinal fluid: an alternative perspective on the protective role of high intracranial pressure in ocular hypertension. Clin. Exp. Optom, 2015, 10.1111/cxo.12332.
223. Wu, I., Shin, S.C., Cao, Y., Bender, I.K., Jafari, N., Feng, G., Lin, S., Cidlowski, J.A., Schleimer, R.P., Lu, N.Z., Selective glucocorticoid receptor translational isoforms reveal glucocorticoid-induced apoptotic transcriptomes. Cell Death Dis., 4, 2013, e453.
224. Xue, W., Comes, N., Borrás, T., Presence of an established calcification marker in trabecular meshwork tissue of glaucoma donors. Investig. Ophthalmol. Vis. Sci. 48:7 (2007), 3184–3194.
225. Yamamoto, Y., Komatsu, T., Koura, Y., Nishino, K., Fukushima, A., Ueno, H., Intraocular pressure elevation after intravitreal or posterior sub-tenon triamcinolone acetonide injection. Can. J. Ophthalmol. 43:1 (2008), 42–47.
226. Yang, X., Luo, C., Cai, J., Powell, D.W., Yu, D., Kuehn, M.H., Tezel, G., Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina. Investig. Ophthalmol. Vis. Sci. 52:11 (2011), 8442–8454.
227. Yuan, Y., Call, M.K., Yuan, Y., Zhang, Y., Fischesser, K., Liu, C.Y., Kao, W.W., Dexamethasone induces cross-linked actin networks in trabecular meshwork cells through noncanonical wnt signaling. Investig. Ophthalmol. Vis. Sci. 54:10 (2013), 6502–6509.
228. Zhan, G.L., Miranda, O.C., Bito, L.Z, L.Z., Steroid glaucoma: corticosteroid-induced ocular hypertension in cats. Exp. Eye Res. 54 (1992), 211–218.
229. Zhang, H.N., He, Y.H., Zhang, G.S., Luo, M.S., Huang, Y., Wu, X.Q., Liu, S.M., Luo, J.D., Chen, M.S., Endogenous glucocorticoids inhibit myocardial inflammation induced by lipopolysaccharide: involvement of regulation of histone deacetylation. J. Cardiovasc. Pharmacol. 60 (2012), 33–41.
230. Zhang, X., Clark, A.F., Yorio, T., Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor-beta. Investig. Ophthalmol. Vis. Sci. 46 (2005), 4607–4616.
231. Zhang, X., Ognibene, C.M., Clark, A.F., Yorio, T., Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor β. Exp. Eye Res. 84 (2007), 275–284.
232. Zhang, X., Clark, A.F., Yorio, T., FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Investig. Ophthalmol. Vis. Sci. 49 (2008), 1037–1047.
233. Zhang, Z., Wu, S., Jonas, J.B., Zhang, J., Liu, K., Lu, Q., Wang, N., Dynein, kinesin and morphological changes in optic nerve axons in a rat model with cerebrospinal fluid pressure reduction: the Beijing Intracranial and Intraocular Pressure (iCOP) study. Acta Ophthalmol, 2015, 10.1111/aos.12768.
234. Zhao, D., He, Z., Vingrys, A.J., Bui, B.V., Nguyen, C.T., The effect of intraocular and intracranial pressure on retinal structure and function in rats. Physiol. Rep., 3(8), 2015, e12507.
235. Zheng, Y., Ishiguro, H., Ide, H., Inoue, S., Kashiwagi, E., Kawahara, T., Jalalizadeh, M., Reis, L.O., Miyamoto, H., Compound A inhibits bladder cancer growth predominantly via glucocorticoid receptor transrepression. Mol. Endocrinol. 29:10 (2015), 1486–1497.
236. Zhuo, Y.H., He, Y., Leung, K.W., Hou, F., Li, Y.Q., Chai, F., Ge, J., Dexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells. Mol. Vis. 16 (2010), 61–71.